David Southwell: CEO of Volastra Therapeutics

from BioBoss · host David Southwell

David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a vulnerability of cancers.

Episode metadata supplied by the publisher feed · Published Feb 28, 2026

Embed this episode

Attribution link and audio player

Ready to play

David Southwell: CEO of Volastra Therapeutics

0:00 31:26

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioBoss?

This episode is 31 minutes long.

When was this BioBoss episode published?

This episode was published on February 28, 2026.

Can I download this BioBoss episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!